A Predictive Model for Temporal Artery Biopsy in the Setting of Suspected Giant Cell Arteritis: A Validation Study.
Journal
Ophthalmic plastic and reconstructive surgery
ISSN: 1537-2677
Titre abrégé: Ophthalmic Plast Reconstr Surg
Pays: United States
ID NLM: 8508431
Informations de publication
Date de publication:
Historique:
pubmed:
18
7
2020
medline:
25
5
2021
entrez:
18
7
2020
Statut:
ppublish
Résumé
A previously published predictive model based on threshold parameters for erythrocyte sedimentation rate, c-reactive protein, and platelet count demonstrated that 40% of patients who underwent biopsy may not have required it. The current study was performed to evaluate the model's performance on an independent data set. This is a retrospective consecutive series of patients undergoing temporal artery biopsy (TAB) in a single health region in Canada. The model was applied to a multicenter cohort of patients undergoing TAB by a variety of surgical services. A centralized pathological database serving multiple institutions and surgical services was used to identify patients undergoing TAB. Over a 7-year period, patients undergoing TAB were identified via a central pathological database. Those who had concurrent illnesses which would likely affect erythrocyte sedimentation rate, c-reactive protein, and platelet count, patients on steroids for >2 weeks by the time of biopsy, and those with missing serum markers were excluded. The previously developed model was applied to the 222 patients enrolled. The model correctly identified 29% of patients with a pretest probability of 0% for a positive biopsy and 9% with a pretest probability of 100%, suggesting that in total, 38% of patients could have avoided TAB. The results of this independent data set support the previously published predictive formula. Utilizing a simple, clinically applicable predictive model of the pretest probabilities, approximately 38% of TAB currently being performed may be avoided. The results suggest that evaluation with a prospective multicentre study would be appropriate.
Identifiants
pubmed: 32675724
pii: 00002341-202105001-00005
doi: 10.1097/IOP.0000000000001771
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
S23-S26Informations de copyright
Copyright © 2021 The American Society of Ophthalmic Plastic and Reconstructive Surgery, Inc.
Déclaration de conflit d'intérêts
The authors have no financial or conflicts of interest to disclose.
Références
Salvarani C, Macchioni P, Zizzi F, et al. Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy Arthritis Rheum. 1991; 34:351–356
Lawrence RC, Felson DT, Helmick CG, et al.; National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II Arthritis Rheum. 2008; 58:26–35
Gonzalez-Gay MA, Miranda-Filloy JA, Lopez-Diaz MJ, et al. Giant cell arteritis in northwestern Spain: a 25-year epidemiologic study Medicine (Baltimore). 2007; 86:61–68
Caselli RJ, Hunder GG, Whisnant JP.Neurologic disease in biopsy-proven giant cell (temporal) arteritis Neurology. 1988; 38:352–359
Säve-Söderbergh J, Malmvall BE, Andersson R, et al. Giant cell arteritis as a cause of death. Report of nine cases JAMA. 1986; 255:493–496
Kale N, Eggenberger E.Diagnosis and management of giant cell arteritis: a review Curr Opin Ophthalmol. 2010; 21:417–422
Aiello PD, Trautmann JC, McPhee TJ, et al. Visual prognosis in giant cell arteritis Ophthalmology. 1993; 100:550–555
Salvarani C, Cimino L, Macchioni P, et al. Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis Arthritis Rheum. 2005; 53:293–297
González-Gay MA, García-Porrúa C, Llorca J, et al. Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients Medicine (Baltimore). 2000; 79:283–292
Hunder GG, Arend WP, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction Arthritis Rheum. 1990; 33:1065–1067
Weis E, Toren A, Jordan D, et al. Development of a predictive model for temporal artery biopsies Can J Ophthalmol. 2017; 52:599–605
Proven A, Gabriel SE, Orces C, et al. Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes Arthritis Rheum. 2003; 49:703–708
Sudlow C.Diagnosing and managing polymyalgia rheumatica and temporal arteritis. Sensitivity of temporal artery biopsy varies with biopsy length and sectioning strategy BMJ. 1997; 315:549
Gajree S, Borooah S, Dhillon N, et al. Temporal artery biopsies in south-east Scotland: a five year review J R Coll Physicians Edinb. 2017; 47:124–128
Papadakis M, Kaptanis S, Kokkori-Steinbrecher A, et al. Temporal artery biopsy in the diagnosis of giant cell arteritis: Bigger is not always better Am J Surg. 2018; 215:647–650
Aghdam KA, Sanjari MS, Manafi N, et al. Temporal artery biopsy for diagnosing giant cell arteritis: a ten-year review J Ophthalmic Vis Res. 2020; 15:201–209
Niederkohr RD, Levin LA.Management of the patient with suspected temporal arteritis a decision-analytic approach Ophthalmology. 2005; 112:744–756
Lenton J, Donnelly R, Nash JR.Does temporal artery biopsy influence the management of temporal arteritis? QJM. 2006; 99:33–36
Jonasson F, Cullen JF, Elton RA.Temporal arteritis. A 14-year epidemiological, clinical and prognostic study Scott Med J. 1979; 24:111–117
Hall S, Hunder GG.Is temporal artery biopsy prudent? Mayo Clin Proc. 1984; 59:793–796
Gunawardene AR, Chant H.Facial nerve injury during temporal artery biopsy Ann R Coll Surg Engl. 2014; 96:257–260
Bhatti MT, Goldstein MH.Facial nerve injury following superficial temporal artery biopsy Dermatol Surg. 2001; 27:15–17
Slavin ML.Brow droop after superficial temporal artery biopsy Arch Ophthalmol. 1986; 104:1127
Mahr A, Saba M, Kambouchner M, et al. Temporal artery biopsy for diagnosing giant cell arteritis: the longer, the better? Ann Rheum Dis. 2006; 65:826–828
Ypsilantis E, Courtney ED, Chopra N, et al. Importance of specimen length during temporal artery biopsy Br J Surg. 2011; 98:1556–1560
Alberts M.Temporal arteritis: improving patient evaluation with a new protocol Perm J. 2013; 17:56–62
Varma D, O’Neill D.Quantification of the role of temporal artery biopsy in diagnosing clinically suspected giant cell arteritis Eye (Lond). 2004; 18:384–388